Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases
- 1 June 2022
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 234, 108046
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 224 references indexed in Scilit:
- Inhibition of soluble epoxide hydrolase bycis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertensionClinical Science, 2012
- The role of 20-HETE in androgen-mediated hypertensionProstaglandins & Other Lipid Mediators, 2011
- Role of Soluble Epoxide Hydrolase in the Sex-Specific Vascular Response to Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stressCardiovascular Research, 2009
- ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthmaProceedings of the National Academy of Sciences, 2008
- Eicosanoid signalling pathways in the heartCardiovascular Research, 2008
- Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formationBiochemical Journal, 2007
- Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)Prostaglandins & Other Lipid Mediators, 2007
- Antagonism of the prostaglandin D 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humansProceedings of the National Academy of Sciences, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002